Credit rating
Company information
About VasDeBlock medical ApS
VasDeBlock medical ApS (CVR number: 37525758) is a company from FAXE. The company reported a net sales of 0.1 mDKK in 2023. The operating profit percentage was poor at -93.7 % (EBIT: -0.1 mDKK), while net earnings were -56.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was -91 %, which can be considered poor and Return on Equity (ROE) was -109.6 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 77 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. VasDeBlock medical ApS's liquidity measured by quick ratio was 4.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | 16.67 | 60.00 | |||
Gross profit | -32.71 | - 247.11 | -68.02 | -96.66 | -56.20 |
EBIT | -47.85 | - 262.25 | -83.17 | - 112.22 | -56.20 |
Net earnings | -48.07 | - 262.94 | -83.46 | - 112.46 | -56.18 |
Shareholders equity total | 69.91 | 74.06 | 50.52 | 32.25 | 70.26 |
Balance sheet total (assets) | 75.18 | 112.12 | 50.52 | 32.25 | 91.24 |
Net debt | -25.28 | -65.40 | -16.74 | -27.46 | -86.86 |
Profitability | |||||
EBIT-% | -287.1 % | -93.7 % | |||
ROA | -50.4 % | -280.0 % | -102.3 % | -271.2 % | -91.0 % |
ROE | -51.2 % | -365.3 % | -134.0 % | -271.8 % | -109.6 % |
ROI | -50.9 % | -364.3 % | -133.5 % | -271.2 % | -109.6 % |
Economic value added (EVA) | -51.05 | - 254.98 | -60.90 | -88.25 | -26.12 |
Solvency | |||||
Equity ratio | 93.0 % | 66.1 % | 100.0 % | 100.0 % | 77.0 % |
Gearing | |||||
Relative net indebtedness % | -120.0 % | -109.8 % | |||
Liquidity | |||||
Quick ratio | 5.6 | 2.2 | -32 246.0 | 4.3 | |
Current ratio | 5.6 | 2.2 | -32 246.0 | 4.3 | |
Cash and cash equivalents | 25.28 | 65.40 | 16.74 | 27.46 | 86.86 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | 146.9 % | 117.1 % | |||
Credit risk | |||||
Credit rating | B | B | B | C | B |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.